Structure based design: Identification of the clinical candidate ABBV-744, a first-in-class highly BDII-selective BET bromodomain inhibitor

Le Wang

George Sheppard

Steven Fidanze

Lisa Hasvold

Dachun Liu

John Pratt

Mai-ha Bui

Emily Faivre

Xiaoli Huang

Xiaoyu Lin

Denise Wilcox

Yu Shen

Daniel Albert

Warren Kati

Keith McDaniel

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com